Figure.
Prostate carcinoma-specific survival after radical prostatectomy for patients with confirmed locally advanced tumors (pT3a, pT3b, or pT4) and/or confirmed lymph-node metastases (pN+) and/or preoperative PSA >20 ng/mL and or Gleason score ≥8 in the prostatectomy specimen. The dotted lines show the 95% confidence interval. a) Prostate carcinoma-specific survival, stratified according to pT stage. b) Prostate carcinoma-specific survival in patients with lymph-node metastases. c) Prostate carcinoma-specific survival in patients with preoperative PSA >20 ng/mL. d) Prostate carcinoma-specific survival in patients with prostatectomy Gleason score ≥8.